サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1768802

バイオ汚染除去の世界市場

Bio Decontamination

出版日
ページ情報
英文 177 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.47円
バイオ汚染除去の世界市場
出版日: 2025年07月11日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 177 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

バイオ汚染除去の世界市場は2030年までに2億6,880万米ドルに達する見込み

2024年に2億600万米ドルと推定されるバイオ汚染除去の世界市場は、2024年から2030年にかけてCAGR 4.5%で成長し、2030年には2億6,880万米ドルに達すると予測されます。本レポートで分析したセグメントの1つである機器は、CAGR 4.2％を記録し、分析期間終了時には1億2,210万米ドルに達すると予測されます。サービス分野の成長率は、分析期間でCAGR 5.1％と推定されます。

米国市場は5,620万米ドルと推定、中国はCAGR4.3%で成長予測

米国のバイオ汚染除去市場は、2024年には5,620万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに4,230万米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは4.3%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ4.2％と3.5％と予測されています。欧州では、ドイツがCAGR 3.7%で成長すると予測されています。

世界のバイオ汚染除去市場- 主要動向と促進要因のまとめ

今日の世界でバイオ汚染除去が不可欠な理由とは？

今日の世界では、生物学的汚染リスクに対する意識が著しく高まっているため、バイオ汚染除去はヘルスケア、製薬、食品加工、公共スペースなど、さまざまな業界で重要な業務となっています。バイオ汚染除去では、細菌、ウイルス、真菌、芽胞などの有害な病原体を、表面、空気、機器から標的を定めて除去または不活化することで、感染リスクを低減し、汚染を防止し、製品と人の両方の安全を確保します。例えばヘルスケア環境では、厳格なバイオ汚染除去が、年間数百万人の患者に影響を与え、深刻な健康リスクをもたらす院内感染（HAI）の蔓延を防ぐために不可欠です。同様に、製薬会社や研究所の汚染は、たとえ微量であっても、製品の品質、研究成果、規制遵守を脅かす可能性があり、厳格な汚染除去プロトコルの重要性を強調しています。COVID-19の大流行は、世界中の組織が従業員と顧客の両方の安全を確保するために、接触頻度の高い場所を除菌する確実な方法を求めていることから、バイオ汚染除去の必要性をさらに浮き彫りにしました。感染症対策と衛生基準の認知度が高まる中、バイオ汚染除去は多くの産業において、安全で衛生的でコンプライアンスに準拠した環境を維持するために不可欠な存在となり、最終的には、相互の結びつきが強まる空間における公衆衛生と安全の礎としての役割を果たしています。

どのような先端技術がバイオ汚染除去を形成しているのでしょうか？

最近のテクノロジーの進歩は、バイオ汚染除去に革命をもたらし、プロセスをより速く、より効果的に、そして環境に優しくする様々な革新的な方法を提供しています。最も画期的な技術革新のひとつは、気化過酸化水素（VHP）除染の開発です。これは、過酸化水素の蒸気を密閉された環境に分散させることで、広範囲の病原菌を除去するものです。この方法は、届きにくい場所にも浸透するため非常に効果的で、有害な残留物を残すことなく、複雑な表面や繊細な機器を完全に殺菌することができます。紫外線C（UV-C）光技術も広く採用されるようになり、特に病院、研究所、人通りの多い公共エリアなどに適した、表面や空気の除染に化学薬品を使わない迅速なアプローチを提供しています。UV-Cシステムがよりポータブルでコスト効率に優れたものになるにつれ、HVACシステムから公共交通機関まで、さまざまな環境で導入されるようになっています。ロボット工学と自動化により、これらの技術はさらに強化され、正確で一貫性のある塗布が可能になり、人手への依存が減ることで、ミスの可能性を最小限に抑え、汚染された空間を包括的にカバーできるようになりました。オゾン除染やイオン化過酸化水素などの追加技術は、広いオープンエリアやエアハンドリングシステムを効果的に除染する能力で人気を集めています。このような技術の進歩により、バイオ汚染除去は、より迅速で、より安全で、より適応性の高いプロセスへと変貌を遂げ、さまざまな部門が厳格な衛生基準を維持し、病原菌の感染リスクを低減できるようになっています。

企業がバイオ汚染除去を導入する際に直面する課題とは？

バイオ汚染除去の導入には、明確な利点があるにもかかわらず、特に業務の中断、規制遵守、コスト管理に関する大きな課題があります。VHPのような多くの除染方法では、最適な蒸気濃度と効果を確保するために、プロセス中に施設を一時的に閉鎖し、気密状態にする必要があります。このようなダウンタイムは、病院や製造工場など、連続運転が必要な環境では特に課題となります。さらに、厳格な安全規制や環境規制を遵守することは極めて重要です。ある種の除染化学物質は、正しく適用・廃棄されなければ、作業員に健康上のリスクをもたらし、環境に悪影響を及ぼす可能性があるからです。ヘルスケア、製薬、食品加工などの業界は規制が厳しく、FDA、EPA、OSHAなどの機関が除染プロトコルと作業員の安全性を監督しているため、規制の遵守は実施において譲れない点となっています。さらに、高度な汚染除去技術や手順にかかるコストは、専門的な機器、スタッフのトレーニング、インフラの調整などへの初期投資がかさむため、小規模な組織にとっては大きな障壁となる可能性があります。また、特定の環境に適した除染方法を選択するには、対象となる病原体、施設のレイアウト、処理する表面の性質などの要因を慎重に考慮する必要があり、さらに複雑な要素が加わります。このような課題から、企業がバイオ汚染除去プロセスを導入する際には、戦略的計画と専門家の指導に投資し、業務、安全、規制の要件を効果的に満たす必要があることがわかります。

バイオ汚染除去市場の主な成長促進要因は？

バイオ汚染除去市場は、感染予防に対する意識の高まり、規制要件の進化、除染をより効率的で身近なものにする急速な技術進歩に後押しされ、力強い成長を遂げています。特にヘルスケア環境における感染管理の重視は、HAIやその他の感染症の蔓延を最小限に抑えるように設計された包括的な汚染除去ソリューションに対する大きな需要を生み出しています。特に、医薬品、バイオテクノロジー、食品加工など、機密性の高い製品やデータを扱う業界では、コンプライアンスを確保し、製品の完全性を維持するために、実証済みの汚染除去方法を採用することが求められています。さらに、VHP、UV-Cライト、ロボットシステムなどの技術の進歩は、バイオ汚染除去をより迅速で安全なものにしています。これらの技術革新は、さまざまな環境や運用上の制約に適応できる効果的なソリューションを提供するからです。COVID-19パンデミックをはじめとする感染症の流行は、公共空間におけるバイオ汚染除去の重要性を強調し、交通機関、接客業、小売業、政府施設などの分野からの需要の高まりにつながっています。消費者の衛生と安全に対する意識が高まるにつれ、バイオ汚染除去を優先する企業を支持する傾向が強まり、市場の拡大をさらに後押ししています。これらの促進要因が相まって、バイオ汚染除去市場は前進しており、幅広い産業において衛生、安全、規制遵守を維持するための世界の取り組みにおいて、バイオ汚染除去が重要な役割を果たすようになっています。

セグメント

製品＆サービス（機器、サービス、消耗品）;エンドユーザー（製薬＆医療機器企業、ライフサイエンス＆バイオテクノロジー研究機関、病院＆ヘルスケア施設）

調査対象企業の例

  • Amira S.r.l
  • ClorDiSys Solutions, Inc.
  • Ecolab
  • Fedegari Autoclavi SpA
  • Howorth Air Technology Ltd.
  • JCE Biotechnology
  • Noxilizer, Inc.
  • STERIS PLC
  • TOMI Environmental Solutions Inc.
  • Wenzhou Weike Biological Laboratory Equipment Co. Ltd.

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP21328

Global Bio Decontamination Market to Reach US$268.8 Million by 2030

The global market for Bio Decontamination estimated at US$206.0 Million in the year 2024, is expected to reach US$268.8 Million by 2030, growing at a CAGR of 4.5% over the analysis period 2024-2030. Equipment, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$122.1 Million by the end of the analysis period. Growth in the Services segment is estimated at 5.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$56.2 Million While China is Forecast to Grow at 4.3% CAGR

The Bio Decontamination market in the U.S. is estimated at US$56.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$42.3 Million by the year 2030 trailing a CAGR of 4.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.2% and 3.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.

Global Bio Decontamination Market - Key Trends and Drivers Summarized

Why Is Bio Decontamination Essential in Today’s World?

In today’s world, bio decontamination has become a critical practice across a wide array of industries, including healthcare, pharmaceuticals, food processing, and public spaces, as the awareness of biological contamination risks has risen significantly. Bio decontamination involves the targeted removal or inactivation of harmful pathogens, such as bacteria, viruses, fungi, and spores, from surfaces, air, and equipment to reduce infection risk, prevent contamination, and ensure the safety of both products and people. In healthcare environments, for instance, rigorous bio decontamination is essential to prevent the spread of hospital-acquired infections (HAIs), which impact millions of patients annually and pose serious health risks. Similarly, in pharmaceutical manufacturing and research laboratories, contamination, even at minute levels, can compromise product quality, research outcomes, and regulatory compliance, underlining the importance of stringent decontamination protocols. The COVID-19 pandemic further highlighted the necessity of bio decontamination, as organizations worldwide sought reliable ways to sanitize high-contact areas to ensure the safety of both employees and customers. In light of the growing recognition of infection control and hygiene standards, bio decontamination has become indispensable in maintaining safe, hygienic, and compliant environments across numerous industries, ultimately serving as a cornerstone for public health and safety in increasingly interconnected spaces.

What Advanced Technologies Are Shaping Bio Decontamination?

Recent advancements in technology have revolutionized bio decontamination, offering a range of innovative methods that make the process faster, more effective, and environmentally friendly. One of the most transformative innovations has been the development of vaporized hydrogen peroxide (VHP) decontamination, which involves dispersing hydrogen peroxide vapor into a sealed environment to eliminate a broad spectrum of pathogens. This method is highly effective, as it can penetrate hard-to-reach areas, ensuring complete sterilization of complex surfaces and sensitive equipment without leaving harmful residues. Ultraviolet-C (UV-C) light technology has also become widely adopted, providing a quick, chemical-free approach to surface and air decontamination that is particularly suited for hospitals, laboratories, and high-traffic public areas. As UV-C systems become more portable and cost-effective, they are being deployed in diverse settings, from HVAC systems to public transport. Robotics and automation have further enhanced these technologies, allowing for precise, consistent application and reducing reliance on human labor, which minimizes the potential for error and ensures comprehensive coverage of contaminated spaces. Additional technologies, such as ozone decontamination and ionized hydrogen peroxide, are gaining traction for their ability to sanitize large, open areas and air handling systems effectively. Together, these technological advances are transforming bio decontamination into a faster, safer, and more adaptable process, enabling various sectors to maintain rigorous hygiene standards and reduce pathogen transmission risks.

What Challenges Do Organizations Face in Implementing Bio Decontamination?

Despite the clear benefits, implementing bio decontamination poses significant challenges, particularly related to operational disruption, regulatory compliance, and cost management. Many decontamination methods, such as VHP, require facilities to be temporarily closed off and airtight during the process to ensure optimal vapor concentration and effectiveness, which can disrupt daily operations and lead to productivity losses. This downtime can be particularly challenging in settings that require continuous operation, such as hospitals or manufacturing plants. Moreover, compliance with stringent safety and environmental regulations is crucial, as certain decontamination chemicals, if not applied and disposed of correctly, can pose health risks to personnel and have adverse environmental impacts. Industries like healthcare, pharmaceuticals, and food processing are highly regulated, with agencies like the FDA, EPA, and OSHA overseeing decontamination protocols and worker safety, making adherence to regulations a non-negotiable aspect of implementation. Additionally, the cost of advanced decontamination technologies and procedures can be a significant barrier for smaller organizations, as initial investments in specialized equipment, staff training, and infrastructure adjustments can be substantial. Choosing the appropriate decontamination method for a given environment adds another layer of complexity, requiring careful consideration of factors such as the pathogens being targeted, facility layout, and the nature of surfaces being treated. These challenges underscore the need for organizations to invest in strategic planning and expert guidance when implementing bio decontamination processes to ensure they meet operational, safety, and regulatory requirements effectively.

What Are the Key Growth Drivers in the Bio Decontamination Market?

The bio decontamination market is experiencing strong growth, fueled by rising awareness of infection prevention, evolving regulatory requirements, and rapid technological advancements that make decontamination more efficient and accessible. The emphasis on infection control, particularly in healthcare settings, has created substantial demand for comprehensive decontamination solutions designed to minimize the spread of HAIs and other infectious diseases. Regulatory agencies worldwide are enforcing stricter hygiene standards, especially for industries handling sensitive products or data, such as pharmaceuticals, biotechnology, and food processing, which are required to adopt proven decontamination methods to ensure compliance and maintain product integrity. Additionally, advancements in technologies such as VHP, UV-C light, and robotic systems are making bio decontamination faster and safer, as these innovations provide effective solutions that can adapt to various environments and operational constraints. The increased prevalence of infectious disease outbreaks, including the COVID-19 pandemic, has also underscored the importance of bio decontamination in public spaces, leading to higher demand from sectors such as transportation, hospitality, retail, and government facilities. As consumers become more aware of hygiene and safety, they are more inclined to support businesses that prioritize bio decontamination, further driving market expansion. Collectively, these drivers are propelling the bio decontamination market forward, solidifying its role as a critical component in global efforts to maintain health, safety, and regulatory compliance across a wide range of industries.

SCOPE OF STUDY:

The report analyzes the Bio Decontamination market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product & Service (Equipment, Services, Consumables); End-Use (Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations, Hospitals & Healthcare Facilities)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 42 Featured) -

  • Amira S.r.l
  • ClorDiSys Solutions, Inc.
  • Ecolab
  • Fedegari Autoclavi SpA
  • Howorth Air Technology Ltd.
  • JCE Biotechnology
  • Noxilizer, Inc.
  • STERIS PLC
  • TOMI Environmental Solutions Inc.
  • Wenzhou Weike Biological Laboratory Equipment Co. Ltd.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Global Economic Update
    • Bio Decontamination - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Awareness of Infection Control Drives Growth in Bio Decontamination Market
    • Increasing Use of Bio Decontamination in Healthcare Expands Demand for Effective Solutions
    • Here's How Advances in Decontamination Technologies Enhance Efficacy Against Pathogens
    • Growing Focus on Patient Safety Supports Adoption of Bio Decontamination in Hospitals
    • Rising Demand for Chemical-Free Decontamination Fuels Use of UV and Vapor-Based Solutions
    • Here's How Automation in Decontamination Systems Reduces Labor Costs and Human Error
    • Focus on Minimizing Cross-Contamination Supports Demand for Routine Decontamination Protocols
    • Advancements in Portable Decontamination Devices Expand Applications Beyond Healthcare
    • Growing Demand for Decontamination Solutions in Pharmaceutical and Biotech Labs
    • Here's How Bio Decontamination Enhances Safety in Food Processing and Manufacturing
    • Rising Adoption of Remote Monitoring and Digital Controls Improves Decontamination Accuracy
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Bio Decontamination by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Bio Decontamination by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Bio Decontamination by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Equipment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Pharma & Medical Device Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Pharma & Medical Device Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Pharma & Medical Device Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Life Sciences & Biotech Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Life Sciences & Biotech Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Life Sciences & Biotech Research Organizations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Hospitals & Healthcare Facilities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Hospitals & Healthcare Facilities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for Hospitals & Healthcare Facilities by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 22: World Bio Decontamination Market Analysis of Annual Sales in US$ for Years 2015 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Bio Decontamination Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Bio Decontamination by Product & Service - Equipment, Services and Consumables - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Bio Decontamination by Product & Service - Equipment, Services and Consumables Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Bio Decontamination by Product & Service - Percentage Breakdown of Value Sales for Equipment, Services and Consumables for the Years 2015, 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Bio Decontamination by End-Use - Percentage Breakdown of Value Sales for Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Bio Decontamination by Product & Service - Equipment, Services and Consumables - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Bio Decontamination by Product & Service - Equipment, Services and Consumables Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for Bio Decontamination by Product & Service - Percentage Breakdown of Value Sales for Equipment, Services and Consumables for the Years 2015, 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Bio Decontamination by End-Use - Percentage Breakdown of Value Sales for Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities for the Years 2015, 2025 & 2030
  • JAPAN
    • Bio Decontamination Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Bio Decontamination by Product & Service - Equipment, Services and Consumables - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Bio Decontamination by Product & Service - Equipment, Services and Consumables Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Bio Decontamination by Product & Service - Percentage Breakdown of Value Sales for Equipment, Services and Consumables for the Years 2015, 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Bio Decontamination by End-Use - Percentage Breakdown of Value Sales for Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities for the Years 2015, 2025 & 2030
  • CHINA
    • Bio Decontamination Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Bio Decontamination by Product & Service - Equipment, Services and Consumables - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Bio Decontamination by Product & Service - Equipment, Services and Consumables Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Bio Decontamination by Product & Service - Percentage Breakdown of Value Sales for Equipment, Services and Consumables for the Years 2015, 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Bio Decontamination by End-Use - Percentage Breakdown of Value Sales for Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities for the Years 2015, 2025 & 2030
  • EUROPE
    • Bio Decontamination Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Bio Decontamination by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Bio Decontamination by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Bio Decontamination by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Bio Decontamination by Product & Service - Equipment, Services and Consumables - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Bio Decontamination by Product & Service - Equipment, Services and Consumables Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Bio Decontamination by Product & Service - Percentage Breakdown of Value Sales for Equipment, Services and Consumables for the Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Bio Decontamination by End-Use - Percentage Breakdown of Value Sales for Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities for the Years 2015, 2025 & 2030
  • FRANCE
    • Bio Decontamination Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Bio Decontamination by Product & Service - Equipment, Services and Consumables - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Bio Decontamination by Product & Service - Equipment, Services and Consumables Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for Bio Decontamination by Product & Service - Percentage Breakdown of Value Sales for Equipment, Services and Consumables for the Years 2015, 2025 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Bio Decontamination by End-Use - Percentage Breakdown of Value Sales for Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities for the Years 2015, 2025 & 2030
  • GERMANY
    • Bio Decontamination Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Bio Decontamination by Product & Service - Equipment, Services and Consumables - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Bio Decontamination by Product & Service - Equipment, Services and Consumables Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for Bio Decontamination by Product & Service - Percentage Breakdown of Value Sales for Equipment, Services and Consumables for the Years 2015, 2025 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Bio Decontamination by End-Use - Percentage Breakdown of Value Sales for Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Bio Decontamination by Product & Service - Equipment, Services and Consumables - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Bio Decontamination by Product & Service - Equipment, Services and Consumables Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for Bio Decontamination by Product & Service - Percentage Breakdown of Value Sales for Equipment, Services and Consumables for the Years 2015, 2025 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Bio Decontamination by End-Use - Percentage Breakdown of Value Sales for Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Bio Decontamination Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Bio Decontamination by Product & Service - Equipment, Services and Consumables - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Bio Decontamination by Product & Service - Equipment, Services and Consumables Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for Bio Decontamination by Product & Service - Percentage Breakdown of Value Sales for Equipment, Services and Consumables for the Years 2015, 2025 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Bio Decontamination by End-Use - Percentage Breakdown of Value Sales for Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Bio Decontamination by Product & Service - Equipment, Services and Consumables - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Rest of Europe Historic Review for Bio Decontamination by Product & Service - Equipment, Services and Consumables Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 82: Rest of Europe 15-Year Perspective for Bio Decontamination by Product & Service - Percentage Breakdown of Value Sales for Equipment, Services and Consumables for the Years 2015, 2025 & 2030
    • TABLE 83: Rest of Europe Recent Past, Current & Future Analysis for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Rest of Europe Historic Review for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 85: Rest of Europe 15-Year Perspective for Bio Decontamination by End-Use - Percentage Breakdown of Value Sales for Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Bio Decontamination Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Bio Decontamination by Product & Service - Equipment, Services and Consumables - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific Historic Review for Bio Decontamination by Product & Service - Equipment, Services and Consumables Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 88: Asia-Pacific 15-Year Perspective for Bio Decontamination by Product & Service - Percentage Breakdown of Value Sales for Equipment, Services and Consumables for the Years 2015, 2025 & 2030
    • TABLE 89: Asia-Pacific Recent Past, Current & Future Analysis for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Asia-Pacific Historic Review for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 91: Asia-Pacific 15-Year Perspective for Bio Decontamination by End-Use - Percentage Breakdown of Value Sales for Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Bio Decontamination by Product & Service - Equipment, Services and Consumables - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of World Historic Review for Bio Decontamination by Product & Service - Equipment, Services and Consumables Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of World 15-Year Perspective for Bio Decontamination by Product & Service - Percentage Breakdown of Value Sales for Equipment, Services and Consumables for the Years 2015, 2025 & 2030
    • TABLE 95: Rest of World Recent Past, Current & Future Analysis for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of World Historic Review for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of World 15-Year Perspective for Bio Decontamination by End-Use - Percentage Breakdown of Value Sales for Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities for the Years 2015, 2025 & 2030

IV. COMPETITION